Markers of inflammation (CRP, LDH, IL6), endothelial dysfunction (ICAM1, VCAM1, E-selectin), coagulation (fibrinogen) and fibrinolysis (D dimers) are used in assessing disease severity, prognosis and treatment options. This evidence concerns the gene SELE and endothelial dysfunction.